AMERIPRISE FINANCIAL INC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$5,228,685
-28.0%
115,374
-10.8%
0.00%0.0%
Q2 2023$7,258,564
+92.5%
129,319
+55.1%
0.00%
+100.0%
Q1 2023$3,771,186
+61.6%
83,378
+45.3%
0.00%0.0%
Q4 2022$2,333,000
-66.2%
57,384
-45.0%
0.00%
-66.7%
Q3 2022$6,895,000
+91.9%
104,369
+76.5%
0.00%
+200.0%
Q2 2022$3,593,000
+6.3%
59,132
+9.8%
0.00%0.0%
Q1 2022$3,379,000
-2.9%
53,836
+17.2%
0.00%0.0%
Q4 2021$3,480,000
-90.8%
45,927
-86.4%
0.00%
-91.7%
Q3 2021$37,687,000
-30.9%
336,693
-0.0%
0.01%
-29.4%
Q2 2021$54,520,000
-4.0%
336,770
-27.8%
0.02%
-10.5%
Q1 2021$56,819,000
-17.1%
466,292
+3.9%
0.02%
-20.8%
Q4 2020$68,501,000
+30.3%
448,896
-28.8%
0.02%
+14.3%
Q3 2020$52,583,000
-32.9%
630,163
-40.9%
0.02%
-38.2%
Q2 2020$78,383,000
+126.4%
1,066,578
+30.7%
0.03%
+88.9%
Q1 2020$34,615,000
+21.0%
816,207
+73.7%
0.02%
+50.0%
Q4 2019$28,612,000
+3294.1%
469,773
+2183.7%
0.01%
Q3 2019$843,000
-13.2%
20,571
-0.2%
0.00%
Q2 2019$971,000
+13.8%
20,608
-13.7%
0.00%
Q1 2019$853,000
+31.6%
23,887
+5.4%
0.00%
Q4 2018$648,000
-69.9%
22,673
-53.3%
0.00%
-100.0%
Q3 2018$2,151,000
-28.2%
48,500
-7.4%
0.00%0.0%
Q2 2018$2,994,000
+155.7%
52,402
+93.1%
0.00%0.0%
Q1 2018$1,171,00027,1330.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2021
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders